Milrinone attenuates serotonin-induced pulmonary hypertension and bronchoconstriction in dogs

Anesthesia and Analgesia

Volumn 90, Issue 4, 2000, Pages 790-794

  Hashiba, Eiji ^a   Hirota, Kazuyoshi ^a   Yoshioka, Hideki ^a   Hashimoto, Yoshio ^a   Kudo, Tsuyoshi ^a   Sato, Tetsumi ^a   Matsuki, Akitomo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BRONCHOSPASM; DOG; DRUG EFFECT; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 0034108725     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200004000-00004     Document Type: Article

References (25)

1. Eichhorn EJ, Konstam MA, Weiland DS, et al. Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;60:1329-33.
2. Karlsberg RP, DeWood MA, DeMaria AN, et al. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Clin Cardiol 1996;19:21-30.
3. Feneck RO. The European Milrinone Multicentre Trial Group. Intravenous milrinone following cardiac surgery. I. Effects of bolus infusion followed by variable dose maintenance infusion. J Cardiothorac Vase Anesth 1992;6:554-62.
4. Silver PJ, Hamel LT, Perrone MH, et al. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. Eur J Pharmacol 1988;150:85-94.
5. Fujimoto S. Effect of pimobendan, its active metabolite UD-CG 212, and milrinone on isolated blood vessels. Eur J Pharmacol 1994;265:159-66.
6. Barnes PJ. Cyclic nucleotides and phosphodiesterases and airway function. Eur Respir J 1995;8:457-62.
7. Torphy TJ, Undem BJ, Cieslinski LB, et al. Identification, characterization and functional role phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 1993;265: 1213-23.
8. Lugnier C, Komas N. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. Eur Heart J 1993;14:141-8.
9. Crilley TK, Wanstall JC, Bonnet PA. Vasorelaxant effect of SCA40 (a phosphodiesterase III inhibitor) in pulmonary vascular preparations in rats. Clin Exp Pharmacol Physiol 1998;25: 355-60.
10. Underwood DC, Kotzer CJ, Bochnowicz S, et al. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J Pharmacol Exp Ther 1994;270:250-9.
11. Tomkinson A, Karlsson JA, Raeburn D. Comparison of the effects of selective inhibitors of phosphodiesterase types III and IV in airway smooth muscle with differing β-adrenoceptor subtypes. Br J Pharmacol 1993;108:57-61.
12. Humphrey PPA. The effects of α-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein. Br J Pharmacol 1978;63:671-5.
13. Takeda J, Masuda J, Fukushima K. Droperidol prevents serotonin-induced bronchospasm, pulmonary hypertension and intrapulmonary shunt [letter]. Anesth Analg 1992;74:316.
14. Sanders-Bush E, Mayer S. 5-hydroxytryptamine (serotonin) receptor agonists and antagonists. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 5th ed., New York: McGraw-Hill, 1996:249-63.
15. Sato T, Hirota K, Matsuki A, et al. Droperidol inhibits tracheal contraction induced by serotonin, histamine or carbachol in guinea pigs. Can J Anaesth 1996;43:172-8.
16. Hashimoto Y, Hirota K, Otomo N, et al. In vivo direct measurement of the bronchodilating effect of sevoflurane using a superfine fiberoptic bronchoscope: comparison with enflurane and halothane. J Cardiothorac Vase Anesth 1993;10:213-6.
17. Otomo N, Hirota K, Hashimoto Y, et al. In vivo assessment of droperidol-induced bronchial relaxation in dogs using a superfine fibreoptic bronchoscope. Br J Anaesth 1997;78:579-82.
18. Otomo N, Hirota K, Hashimoto Y, et al. Measurement of bronchodilation using a superfine fibreoptic bronchoscope. Br J Anaesth 1997;78:583-5.
19. Hirota K, Otomo N, Hashimoto Y, et al. Effects of thiopental on airway calibre in dogs: direct visualization method using a superfine fibreoptic bronchoscope. Br J Anaesth 1998;81:203-7.
20. Hirota K, Sato T, Hashimoto Y, et al. Relaxant effect of magnesium and zinc on histamine-induced bronchoconstriction in dogs. Crit Care Med 1999;27:1159-63.
21. Kudo M, Kudo T, Oyama T. The simultaneous determination of plasma concentration of norepinephrine, epinephrine and dopamine by gas chromatography-mass spectrometry. Masui 1984;33:1099-103.
22. Leeman M, Lejeune P, Melot C, Naeije R. Reduction in pulmonary hypertension and in airway resistance by enoximone (MDL17043) in decompensated COPD. Chest 1987;91:662-6.
23. Gal TJ. Bronchial hyperresponsiveness and anesthesia: physiologic and therapeutic perspectives. Anesth Analg 1994;78: 559-73.
24. Tobias JD, Kubos KL, Hirshman CA. Aminophylline does not attenuate histamine-induced airway constriction during halothane anesthesia. Anesthesiology 1989;71:723-9.
25. Brown RH, Herold CJ, Hirshman CA, et al. In vivo measurements of airway reactivity using high-resolution computed tomography. Am Rev Respir Dis 1991;144:208-12.